Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Nonrulemaking

Requests that the FDA declare that the drug products Benztropine Tablets, 1.5 mg and 3 mg, are suitable for consideration in an Abbreviated New Drug Application.

🏛 Food and Drug Administration (FDA)FDA-2026-P-7927
Pharmaceutical Policy
Documents
7
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 7Supporting & Related Material 4Other 3
📄 Primary document
OtherJul 30, 2026
Completeness Assessment Correspondence
No comment period
Open →